Polymorphisms of glutathione-S-transferases M1, T1, P1 and susceptibility to colorectal cancer in a sample of the Tunisian population

被引:16
作者
Kassab, Asma [1 ]
Msolly, Awatef [1 ,2 ]
Lakhdar, Ramzi [3 ]
Gharbi, Olfa [4 ]
Miled, Abdelhedi [1 ]
机构
[1] Farhat Hached Univ Hosp, Biochem Lab, Sousse, Tunisia
[2] Fac Dent, Dept Biochem, Monastir 5000, Tunisia
[3] Farhat Hached Univ Hosp, Pharmaceut Fac, Dept Biochem & Mol Biol, Monastir, Tunisia
[4] Farhat Hached Univ Hosp, Dept Med Oncol, Sousse, Tunisia
关键词
Colorectal cancer; GSTT1; GSTM1; GSTP1; Polymorphism; DNA ADDUCT LEVELS; GENETIC POLYMORPHISMS; RISK; GSTM1; GSTT1; ISOTHIOCYANATES; GENOTYPES; HUMANS; AGENTS; GSTA1;
D O I
10.1007/s12032-013-0760-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this study, we investigated the associations of polymorphisms in glutathione-S-transferases (GSTs) genes that are GSTM1, GSTT1, and GSTP1, with sporadic colorectal cancer (CRC). Hundred and fifty patients with CRC and 128 healthy controls were genotyped. DNA was isolated from blood samples. Polymorphisms were assessed by polymerase chain reaction-restriction fragment length polymorphism-based methods and polymerase chain reaction multiplex. Logistic regression analyses showed significant risk for CRC associated with GSTP1 homozygotes for Val-105 (OR 4.82; 95 % CI 1.97-11.80) or for individuals who possessed at least one Val-105 allele (OR 2.54; 95 % CI 1.751-3.703). There were no statistically significant differences in the frequency of GSTM1- and GSTT1-null genotypes (p > 0.05). The GSTM1-null was found in 70.47 % of all cases and 70.07 % of controls (OR 0.61; 95 % CI 0.33-1.12). The GSTT1-null genotype was found in 38.77 % of cases and 49.22 % of controls (OR 1.53; 95 % CI 0.94-2.47). No effect of any genotype for GSTM1 and GSTT1 on CRC was detected. But then an association between the polymorphism of the GSTP1 and the CRC susceptibility was detected.
引用
收藏
页数:6
相关论文
共 28 条
[1]  
BROCKMOLLER J, 1993, CANCER RES, V53, P1004
[2]   Metabolic genotypes and risk for colorectal cancer [J].
Butler, WJ ;
Ryan, P ;
Roberts-Thomson, IC .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2001, 16 (06) :631-635
[3]   Simultaneous characterization of glutathione S-transfersase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks [J].
Chen, CL ;
Liu, Q ;
Relling, MV .
PHARMACOGENETICS, 1996, 6 (02) :187-191
[4]   Interindividual variation and organ-specific patterns of glutathione S-transferase alpha, mu, and pi expression in gastrointestinal tract mucosa of normal individuals [J].
Coles, BF ;
Chen, GP ;
Kadlubar, FF ;
Radominska-Pandya, A .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 403 (02) :270-276
[5]   Isothiocyanates as cancer chemopreventive agents: Their biological activities and metabolism in rodents and humans [J].
Conaway, CC ;
Yang, YM ;
Chung, FL .
CURRENT DRUG METABOLISM, 2002, 3 (03) :233-255
[6]   Colorectal cancer [J].
Cunningham, David ;
Atkin, Wendy ;
Lenz, Heinz-Josef ;
Lynch, Henry T. ;
Minsky, Bruce ;
Nordlinger, Bernard ;
Starling, Naureen .
LANCET, 2010, 375 (9719) :1030-1047
[7]  
Curado MP, 2007, CANC INCIDENCE 5 CON, VIX, P107
[8]  
de Jong MM, 2002, CANCER EPIDEM BIOMAR, V11, P1332
[9]   GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: A comprehensive meta-analysis [J].
Economopoulos, Konstantinos P. ;
Sergentanis, Theodoros N. .
EUROPEAN JOURNAL OF CANCER, 2010, 46 (09) :1617-1631
[10]   Polymorphism of the Pi class glutathione S-transferase in normal populations and cancer patients [J].
Harris, MJ ;
Coggan, M ;
Langton, L ;
Wilson, SR ;
Board, PG .
PHARMACOGENETICS, 1998, 8 (01) :27-31